Search All Resources
Hepatitis B Vaccines | January 28, 2026
Type: Past Presentation
Program: Hepatitis C
Keywords: #hbv #hcv #hepatitis b #re-vaccinate #serologies #test #vaccine
In this presentation, Dr. Paulina Deming, PharmD, PhC, reviews how to interpret HBV serological test results, identifies screening recommendations, discusses the vaccines available for HBV infections, how to differentiate between the available HBV vaccines and finally, discusses vaccine response and ...
Date added: 01/12/26
Hepatitis C Virus Point of Care RNA Testing: Ideas for Implementation | January 21, 2026
In this presentation, Dr. Alithea Gabrellas, MD, Infectious Diseases Physician, discusses the implementation of point-of-care (POC) HCV RNA testing at Gallup Indian Medical Center, highlights limitations of traditional testing approaches, and explores practical strategies and future directions for improving HCV ...
Date added: 01/9/26
Choosing Antidepressant Medications | January 7, 2026
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #antidepressant #medications #pharmacotherapy
In this presentation, Dr. Jasen Christensen, DO, discusses the range of antidepressants available, reasons to choose and reasons to avoid certain antidepressants, and reviews the importance of antidepressant treatment duration.
Date added: 01/6/26
HCV Care Anywhere – Lessons From The Field | December 17, 2025
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #filed based #hcv #hepatitis c #linkage to care
In this presentation, Dylan Moore discusses a field-based approach to diagnosing, managing, and curing patients with HCV in Arizona. Dylan shares the barriers and successes of the field-based approach to HCV services across Arizona and provides valuable insights to elevate ...
Date added: 12/2/25
Diabetes and HCV | December 3, 2025
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #diabetes #dm #hcc #hcv and diabetes #hepatitis c #hepatocellular carcinoma #type 2 diabetes
In this presentation, Dr. Carol Greenlee, endocrinologist, discusses the relationship of diabetes, liver disease and HCV infection. Dr. Greenlee provides an overview of extra hepatic manifestations of HCV infection, HCV & insulin resistance, how HCV can potentially induce or aggravate ...
Date added: 11/17/25
Medications for Alcohol Use Disorder | November 19, 2025
Type: Past Presentation
Program: Hepatitis C
Keywords: #alcohol #aud #medications #naltrexone #pharmacotherapy #topiramate
In this presentation, Dr. Jasen Christensen, DO, discusses the latest research on medications for alcohol use disorder, including recent studies comparing Naltrexone and Topiramate, and new research regarding Nalrexone’s safety in context of cirrhosis. Dr. Christensen shares the evidence supporting ...
Date added: 11/7/25
HCV Treatment Monitoring: Keeping it Simple | November 5, 2025
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #hcv #hcv cure #hcv monitoring #hcv treatment #hep c #hepatitis
In this session, Dr. Paulina Deming discusses baseline laboratories recommended for HCV treatment evaluation, identifies patients eligible for simplified monitoring and shares HCV treatment monitoring recommendations.
Date added: 10/23/25
Lost in Transaminases? A Map Through the Liver Maze | October 22, 2025
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #cirrhosis #fibrosis #transaminases
In this presentation, Dr. Ellen Green, reviews abnormal LFT patterns, how to assess fibrosis and cirrhosis and recognize the progression of liver disease toward cirrhosis, identifying critical laboratory and clinical signs that warrant further investigation or a hepatology referral.
Date added: 10/7/25
Starting an Effective Model to End the Syndemic at Cass Lake IHS | October 1, 2025
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #harm reduction #naloxone #primary care #sterile equipment #syringe
In this presentation, Whitney Dickson, PharmD, shares the story of Cass Lake Indian Health Service’s syndemic program, reviews the need for hepatitis C and harm reduction services in Tribal communities, and describes the steps participants can take to end the ...
Date added: 09/11/25
Evaluation of Infectious Diseases in People With Substance Use Disorders: An Opportunity for Disease Elimination | September 24, 2025
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #disease #elimination #infectious disease #SUD
In this presentation, Dr. Jorge Mera, Indian Country ECHO Medical Director and Director of Infectious Diseases at Cherokee Nation, discusses the connection between substance use disorders and infectious diseases. He also covers the various types of infectious diseases that may ...
Date added: 08/25/25











































